Therapy News and Research

RSS

Biological bypass found safe for patients with coronary artery disease

A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease, according to a successful trial carried out in Finland.

8 Aug 2017

Gold shines bright in cancer therapy research: New Edinburgh University study

According to latest research, gold particles can be effective in certain cancer therapy areas. Researchers at the Edinburgh University report in their new study that gold particles can help enhance the effectiveness of the agents used for lung cancer cells. The study is published in the scientific journal Angewandte Chemie.

8 Aug 2017

Nanotechnology wonders: Organ healing with a single touch!

Scientists from the Ohio State University Wexner Medical Centre have come up with what sounds like a science fiction - a nanotechnology device that can switch the cell functions in such a way that the failing organs are revived using a single touch.

7 Aug 2017

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

A newly discovered biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs for clinical trials for the disease, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.

7 Aug 2017

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Researchers at the University of Cincinnati begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells.

7 Aug 2017

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

7 Aug 2017

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Compound derived from cannabis may alter blood levels of antiepileptic drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

7 Aug 2017

HIV prevention and treatment being overlooked in older populations

When it comes to HIV prevention and treatment, there is a growing population that is being overlooked -- older adults -- and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

4 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding opioid addiction epidemic in the United States, according to research presented at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

Rush Midlife Center addresses health needs of women going through perimenopause

Rush has launched an innovative program dedicated to the comprehensive care of women 40 years of age and older.

4 Aug 2017

University of Rhode Island professor leads team expanding clinical practice guidelines for neck pain

A professor at the University of Rhode Island led an international team of experts who spent several years revising and expanding clinical practice guidelines for the treatment of neck pain.

3 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

Yoga appears to lessen symptoms of depression

People who suffer from depression may want to look to yoga as a complement to traditional therapies as the practice appears to lessen symptoms of the disorder, according to studies presented at the 125th Annual Convention of the American Psychological Association.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Gene-therapy administered through skin transplants could enable treatment of many diseases

A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases.

3 Aug 2017

Researchers reveal potential of radiomics to improve precision medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.

3 Aug 2017

Therapy News and Research

Biological bypass found safe for patients with coronary artery disease

Gold shines bright in cancer therapy research: New Edinburgh University study

Nanotechnology wonders: Organ healing with a single touch!

Newly discovered biomarker linked to rare metabolic disorders may facilitate better diagnosis

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Tackling food allergies: is immunotherapy the answer?

Compound derived from cannabis may alter blood levels of antiepileptic drugs

HIV prevention and treatment being overlooked in older populations

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

Rush Midlife Center addresses health needs of women going through perimenopause

University of Rhode Island professor leads team expanding clinical practice guidelines for neck pain

Experimental drug protects mice from obesity-related liver disease

Yoga appears to lessen symptoms of depression

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Gene-therapy administered through skin transplants could enable treatment of many diseases

Researchers reveal potential of radiomics to improve precision medicine

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News